Efficacy of soluble IL-4 receptor for the treatment of adults with asthma

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 6, 2001, Pages 963-970

  Borish, Larry C ^a,b,c,d,e   Nelson, Harold S ^a,b,c,d,e   Corren, Jonathan ^a,b,c,d,e   Bensch, George ^a,b,c,d,e   Busse, William W ^a,b,c,d,e   Whitmore, James B ^a,b,c,d,e   Agosti, Jan M ^a,b,c,d,e   Buchmeier, Andrea ^f   Fell, Sue ^f   Fuller, Laura ^f   Gallegos, Christina ^f   Hall, Patty ^f   Kim, Yuni ^f   McHugh, Peggy ^f   Vallery, Sandy ^f   Hanna, Roberta ^f   Bauer, Larry A ^f  

^a UNIVERSITY OF COLORADO   (United States)

^b Allergy Research Foundation   (United States)

^c Allergy Immunology and Asthma Group   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e AMGEN INC   (United States)

^f NONE   (United States)

Author keywords

Asthma; Clinical trials; Cytokines; IL 4; IL 4 receptor; Soluble receptor; Therapy

Indexed keywords

INTERLEUKIN 4 RECEPTOR; RECOMBINANT INTERLEUKIN 4; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOTHELIUM CELL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION;

EID: 0034995872     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.115624     Document Type: Article

References (45)

1. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma
2. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells
3. Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1
4. Differential regulation of IgG1 and IgE synthesis by interleukin 4
5. Nasal mast cells in perennial allergic rhinitis exhibit increased expression of the Fc epsilon RI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells
6. Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes
7. Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes
8. IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils
9. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-I
10. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals
11. IL-4 and TNF-alpha synergize to enhance eosinophil survival [abstract]
12. A novel role for routine IL-4 in vivo: Induction of MUC5AC gene expression and mucin hypersecretion
13. IL-4 directs the development of Th2-1ike helper effectors
14. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells
15. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system
16. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice
17. Enhanced development of Th2-like primary CD4 effectors in response to sustained exposure to limited rIL-4 in vivo
18. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
19. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones
20. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones
21. Interleukin-4 is required for the induction of lung Th2 mucosal immunity
22. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
23. Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice
24. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor
25. Prevention of the development of immediate hypersensitivity and airway hyperresposiveness following in vivo treatment with soluble IL-4 receptor
26. Soluble interleukin-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma
27. Recombinant human interleukin-4 receptor in moderate astopic asthma: A randomized double-blind, placebo-controlled pilot study
28. Aerosolized protein delivery in asthma: Gamma camera analysis and importance of regional deposition [abstract]
29. Standardization of spirometry
30. Evaluation of impairment of health-related quality of life in asthma: Development of a questionnaire for use in clinical trials
31. Measuring quality of life
32. The application of the principle of intention-to-treat to the analysis of clinical trials
33. PCNONLIN and NONLIN84-software for the statistical analysis of nonlinear models
34. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations
35. IL-13, IL-4R alpha and Stat6 are required for expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis
36. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: Lessons from studies with rodent models
37. Osteoporosis induced in mice by overproduction of interleukin 4
38. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate
39. Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome
40. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells
41. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration
42. The role of IL-13 and its receptor in allergy and inflammatory responses
43. Interleukin-13: Central mediator of allergic asthma
44. Requirement for IL-13 independently of IL-4 in experimental asthma